Stephen Taylor

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection

Jianmin Zuo, Alexander C. Dowell, Hayden Pearce et al. · Nature Immunology · 2021 · 418 citations · Full text

Viral Persistence, Adaptive Immune System, Immunology +6

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Jordan R. Barrett, Sandra Belij‐Rammerstorfer, Christina Dold et al. · Nature Medicine · 2020 · 334 citations · Full text

Vaccination, Phase 1/2, Vaccine Development +7

Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

Catherine J. Reynolds, Leo Swadling, Joseph M. Gibbons et al. · Science Immunology · 2020 · 217 citations · Full text

Vaccination, Immunological Memory, Mild Sars-cov-2 Infection +15

Synthesis of polyphenylene from a cis-dihydrocatechol biologically produced monomer

D. G. H. Ballard, Andrew Courtis, Ian M. Shirley et al. · Macromolecules · 1988 · 199 citations

Macromolecular Chemistry, Bioorganic Chemistry, Engineering +20

A biotech route to polyphenylene

D. G. H. Ballard, Andrew Courtis, Ian M. Shirley et al. · Journal of the Chemical Society Chemical Communications · 1983 · 177 citations

Synthetic Macromolecule, Engineering, Biomimetic Chemistry +12